dbo:abstract
|
- Evogene is a computational biology company based in Israel. Evogene Ltd. (NASDAQ:EVGN) has developed a unique computational predictive biology "CPB" platform, which leverages big data with advanced algorithms such as machine learning and other artificial intelligence ("AI"), while adding a deep understanding of biology and advanced biological technologies. Evogene is using its proprietary CPB platform to computationally design and develop next-generation life-science products based upon three core components: microbes, small molecules, and genetic elements. Evogene's computational platform allows it to substantially increase the probability of successful life-science product development, increase the efficacy and reduce the toxicity of its life-science products while reducing time and cost to development. Its strategic partners include BASF (OTCQX:BASFY), Bayer (OTCPK:BAYZF), Corteva (CTVA), ICL Group Ltd. (ICL) as well as various academic and medical institutions. (en)
|
dbo:foundingYear
| |
dbo:industry
| |
dbo:keyPerson
| |
dbo:location
| |
dbo:thumbnail
| |
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 2026 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:foundation
| |
dbp:founder
|
- Dr. Hagai Karchi and Dr. Rafi Meissner (en)
|
dbp:homepage
| |
dbp:industry
| |
dbp:keyPeople
|
- Sarit Firon, Chairperson of Board, Ofer Haviv, President & CEO (en)
|
dbp:location
| |
dbp:logo
|
- Evogene logo New.jpg (en)
|
dbp:name
| |
dbp:subsid
|
- Biomica, Canonic, Lavie Bio, AgPlenus, Castera (en)
|
dbp:tradedAs
| |
dbp:type
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- Evogene is a computational biology company based in Israel. Evogene Ltd. (NASDAQ:EVGN) has developed a unique computational predictive biology "CPB" platform, which leverages big data with advanced algorithms such as machine learning and other artificial intelligence ("AI"), while adding a deep understanding of biology and advanced biological technologies. Evogene is using its proprietary CPB platform to computationally design and develop next-generation life-science products based upon three core components: microbes, small molecules, and genetic elements. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:homepage
| |
foaf:isPrimaryTopicOf
| |
foaf:name
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |